Breaking Barriers: Exploring New Treatment Approaches for Major Depressive Disorder
T. T. Pieters, A. HerremansIntroduction
Depression and anxiety account for an estimated 12 billion lost workdays each year, costing the global economy approximately $1 trillion annually. Despite extensive research, the past 30 years have yielded only limited improvements in the effectiveness of treatments for Major Depressive Disorder (MDD). Numerous scientific disciplines continue to explore potential therapies, yet no approach has delivered a transformative breakthrough. Current efforts at interdisciplinary collaboration remain insufficient, leaving patients in urgent need of more effective solutions.
Objectives
The primary objective is to foster transdisciplinary collaboration among researchers, clinicians, and patients in order to overcome structural and cultural barriers that limit progress. The ultimate goal is to accelerate the development of effective multimodal treatments that significantly improve the lives of individuals living with MDD.
Methods
A critical analysis was conducted to identify the systemic obstacles that hinder collaboration. Key barriers include communication gaps between disciplines, entrenched academic silos, competitive rather than cooperative mindsets, and funding structures that reward that reward interdisciplinary over transdisciplinary collaboration. As countermeasures, the initiative proposes to:
Center the patient perspective to strengthen awareness of the need for collaboration.
Create dedicated spaces—such as patient society events, and healthcare gatherings—for transdisciplinary dialogue.
Identify and integrate currently absent disciplines and patient organizations into existing conversations.
Results
While radical systemic change is beyond immediate scope, initial steps demonstrate that raising awareness and fostering transdisciplinary dialogue are achievable entry points. The way forward includes developing a shared proposition, visualizing problems and solutions (van Baalen et al. Front Psychiatry 2025;15:1463929.), engaging patient societies, and cultivating positive motivation across stakeholders. Together, these steps can break down barriers and lay the groundwork for a transformative paradigm shift in MDD treatment.
Image 1: Long description.